Primo Chemicals Ltd Valuation Shifts to Attractive Amid Mixed Market Returns

Valuation Metrics Signal Improved Price Attractiveness

As of 9 July 2026, Primo Chemicals trades at ₹23.64, down 1.79% from the previous close of ₹24.07. The stock’s 52-week range spans ₹16.21 to ₹31.44, indicating a moderate recovery from its lows but still below its peak levels. The company’s P/E ratio currently stands at 36.62, a notable improvement from prior levels that had been categorised as fair. This shift to an attractive valuation grade reflects a more reasonable price relative to earnings, especially when compared to peers in the commodity chemicals sector.

Similarly, the price-to-book value ratio has adjusted to 1.40, reinforcing the stock’s appeal on a book value basis. This is particularly significant given the sector’s capital-intensive nature, where P/BV often serves as a critical valuation yardstick. The enterprise value to EBITDA (EV/EBITDA) ratio of 10.20 further supports the notion that Primo Chemicals is trading at a more accessible valuation compared to many of its competitors.

Peer Comparison Highlights Relative Value

When benchmarked against key peers, Primo Chemicals’ valuation stands out as attractive. For instance, Sanstar Chemicals trades at a P/E of 65.02 and an EV/EBITDA of 55.74, categorised as expensive. Stallion India and Titan Biotech are marked as very expensive with P/E ratios of 47.66 and 55.17 respectively, and EV/EBITDA multiples well above Primo Chemicals’ level. Even companies like Nitta Gelatin and Indo Borax & Chemicals, with P/E ratios of 17.08 and 31.45 respectively, are considered expensive or very expensive relative to Primo’s valuation.

Among the peer group, only a few companies such as TGV Sraac and Gulshan Polyols present more attractive valuations, with P/E ratios of 8.22 and 26.91 respectively. However, Primo Chemicals’ PEG ratio of 0.11 is particularly compelling, suggesting undervaluation relative to its earnings growth potential. This low PEG ratio contrasts sharply with some peers who have PEG ratios exceeding 1.0 or are not meaningful due to zero or negative earnings growth.

Financial Performance and Returns: A Mixed Picture

Despite the improved valuation, Primo Chemicals’ recent stock performance has been mixed. Over the past week, the stock declined by 1.46%, underperforming the Sensex’s modest 0.54% fall. The one-month return shows a sharper contrast, with Primo Chemicals down 4.60% while the Sensex gained 4.05%. Year-to-date, the stock has marginally declined by 1.29%, outperforming the Sensex’s 10.23% loss, which indicates some resilience amid broader market weakness.

However, over longer horizons, the stock’s performance has been less encouraging. The one-year return is negative at -10.18%, slightly worse than the Sensex’s -8.61%. The three-year return is deeply negative at -61.67%, a stark contrast to the Sensex’s 17.19% gain. On the other hand, the five-year and ten-year returns are impressive, with gains of 43.80% and 618.54% respectively, significantly outpacing the Sensex’s 45.53% and 182.02% returns over the same periods. This suggests that while the stock has faced recent challenges, its long-term growth story remains intact.

Operational Metrics and Quality Grades

Primo Chemicals’ return on capital employed (ROCE) and return on equity (ROE) remain modest at 2.95% and 3.83% respectively, reflecting operational challenges in generating strong profitability. These ratios are below what many investors might expect for a micro-cap in the commodity chemicals sector, which often demands efficient capital utilisation to justify valuations.

The company’s MarketsMOJO score currently stands at 64.0, with a grade of Hold, downgraded from Buy on 22 June 2026. This downgrade reflects the tempered outlook given the company’s operational metrics and recent price performance, despite the more attractive valuation parameters. The micro-cap status also implies higher volatility and risk, which investors should weigh carefully.

Sector and Market Context

The commodity chemicals sector remains competitive and cyclical, with pricing pressures and raw material cost fluctuations impacting margins. Primo Chemicals’ valuation improvement may partly reflect market recognition of these sector dynamics stabilising or the stock’s price correction aligning better with fundamentals. However, investors should remain cautious given the company’s relatively low profitability and the presence of more attractively valued peers with stronger operational metrics.

Investor Takeaway: Valuation Opportunity Amid Operational Headwinds

Primo Chemicals Ltd’s recent shift in valuation from fair to attractive presents a potential entry point for investors seeking value in the commodity chemicals space. The stock’s P/E of 36.62 and P/BV of 1.40 compare favourably against many peers, signalling a more reasonable price relative to earnings and book value. The low PEG ratio of 0.11 further suggests undervaluation relative to growth expectations.

However, the company’s modest ROCE and ROE, combined with recent share price underperformance and a Hold rating from MarketsMOJO, indicate caution. The micro-cap status adds an element of risk, and the sector’s cyclical nature means investors should monitor commodity price trends and operational improvements closely.

Long-term investors may find Primo Chemicals’ decade-plus returns compelling, but near-term challenges and peer comparisons suggest a balanced approach. Those seeking exposure to the commodity chemicals sector might consider Primo Chemicals alongside other attractively valued peers or explore alternatives recommended by analytical tools that assess fundamentals, momentum, and value comprehensively.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today